Joseph Coppola has extensive experience in the area of biotechnology and pharmaceutical patent prosecution, opinions, interferences and licensing. Prior to joining Kenyon, Dr. Coppola spent more than five years as a senior attorney in the biotechnology practice group at Merck, where he obtained patents and provided validity and infringement opinions in various areas such as newly discovered genes, drug discovery assays, Alzheimer’s disease research, functional genomics, ion channels, hepatitis C virus, inflammation, combinatorial chemistry, proteomics, diabetes, monoclonal antibodies, the crystal structures of proteins, transgenic mice and vaccines. He also provided guidance to management in connection with patent issues arising in various licensing matters. Dr. Coppola helped defend several Merck patents or patent applications that became involved in interferences or European oppositions.
Dr. Coppola received his Ph.D. in molecular biology and conducted research in the area of oncogenes at Princeton University and Bristol-Myers Squibb. His work involved studying the relationship between oncogene expression and the differentiation and transformation of cells as well as structure/function studies of oncogene activation. He published the results of his research in journals such as Nature, Proceedings of the National Academy of Sciences, Journal of Molecular Biology, Oncogene, and Molecular and Cellular Biology. Dr. Coppola was a Damon Runyon-Walter Winchell Cancer Fund Fellow.
- "Thoughts on Oral Arguments in Gene Patent Case," Law360, April 17, 2013.